Journey to Health: Death to Cancer Cells

Four researchers recently earned a pilot grant for a project that allows them to use an anti-inflammatory drug to decrease damage to the heart muscles — a side effect of cancer treatment — while increasing death to cancer cells.

The leads on the project include:

• Shailaja Allani, Ph.D., associate scientist, Charles E. Schmidt College of Science
• Herbert Weissbach, Ph.D., Emeritus professor, Charles E. Schmidt College of Science
• Claudia Rodrigues, Ph.D., associate professor of biomedical science, Charles E. Schmidt College of Medicine
• Howard Prentice, Ph.D., professor of biomedical science, Charles E. Schmidt College of Medicine